LEXINGTON, Mass., April 13, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the BioCentury Future Leaders in the Biotech Industry Conference at 2:00 p.m. ET on April 20, 2012, in New York City.
